Predicting the cause of brief double vision episodes
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial looks at a way to predict what causes short-lasting double vision. It may help doctors choose the right next steps faster after symptoms stop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an episode of double vision that went away within 24 hours
- Your double vision episode happened within the last 8 days
- You must be able to share details about the episode with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures eye movements in people with sudden dizziness caused by inner ear or brain problems. It aims to help doctors tell the difference between these causes more accurately.
This trial tests ways to improve control of intermittent exotropia, a type of eye misalignment that comes and goes, without surgery for at least 6 months.
This study is for people who have brief episodes of dizziness or vertigo that might be caused by temporary blood flow problems in the back part of the brain (the vertebrobasilar system). It will follow participants over time to better understand and treat these episodes.
This trial tests a new treatment for children aged 8 to 12 with lazy eye (amblyopia) who have stopped standard treatments. The goal is to see if this therapy can improve vision in the weaker eye.
This study looks at how people with dizziness from concussion or other causes (like vestibular migraine) react to visual motion. It tests balance during specific visual challenges to understand why dizziness happens.
This study looks at whether vision therapy (eye exercises) can help people who have eye teaming problems after a mild concussion. It aims to improve symptoms like eye strain, headaches, and double vision when reading or using screens.
Hear when a new Diplopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.